NCT03580824: A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants
- State
- Completed
- Phase
- Phase 1 and Phase 2
- People
- 91 taking part
- Started
- 30 Apr 2019
- Primary completion
- 14 Jun 2022
- Arms
- Group 1, Group 2, Group 3
- Results
- None posted
- 9 Jul 2018: Trial registered
- 30 Apr 2019: Trial started
- 14 Jun 2022: Trial completed